Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)
Frequently Asked Questions About Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)
Does Enanta have any FDA-approved drugs?
Yes, Enanta Pharmaceuticals developed and received FDA approval for its prominent drug, Ritonavir, which is part of the hepatitis C treatment regimen. The company has a track record of successfully bringing innovative therapeutic solutions to the market.
How can I invest in Enanta Pharmaceuticals?
Investing in Enanta Pharmaceuticals can be done through a brokerage account that allows trading on the Nasdaq stock exchange. Prospective investors should conduct thorough research and consider their investment strategy, including evaluating the company's growth potential and market conditions.
How does Enanta Pharmaceuticals approach patient needs?
Enanta Pharmaceuticals prioritizes patient needs by engaging in thorough research and understanding the challenges faced by patients with infectious diseases and liver disorders. Their focus on unmet medical needs drives the development of effective therapies that better the lives of individuals affected by these conditions.
How does Enanta Pharmaceuticals contribute to the community?
Enanta Pharmaceuticals contributes to the community through philanthropic efforts, including partnerships with healthcare organizations and supporting initiatives focused on health and wellness. The company is dedicated to corporate social responsibility and enhancing the well-being of the communities in which it operates.
How does Enanta Pharmaceuticals ensure corporate governance?
Enanta Pharmaceuticals adheres to high standards of corporate governance, ensuring transparency and accountability in its operations. The company emphasizes ethical practices and compliance with legal regulations while fostering a culture of integrity among its employees and executives.
How does Enanta Pharmaceuticals handle research and development?
Enanta Pharmaceuticals invests significantly in research and development to explore new therapeutic avenues. The company employs cutting-edge technologies and collaborates with academic and industry partners to advance its pipeline and bring innovative solutions to market.
What are some key areas of research for Enanta Pharmaceuticals?
Enanta Pharmaceuticals focuses on several key areas, including antiviral therapies particularly for hepatitis C and COVID-19, as well as treatments for non-alcoholic steatohepatitis (NASH) and other liver diseases. Their research leverages their proprietary drug discovery platform.
What challenges does Enanta Pharmaceuticals face?
Enanta Pharmaceuticals faces several challenges typical in the biotechnology sector, including regulatory hurdles, competition from other drug developers, and the need for continuous innovation to meet evolving patient needs in a rapidly changing healthcare landscape.
What does Enanta Pharmaceuticals, Inc. do?
Enanta Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs for infectious diseases and liver diseases. The company uses its expertise in medicinal chemistry and drug design to create novel therapies, primarily targeting viral infections and other serious medical conditions.
What financial information is available for Enanta Pharmaceuticals?
Financial information for Enanta Pharmaceuticals, including revenue, expenditures, and stock performance, can be found in their quarterly earnings reports available on their website. These reports provide insights into the company's financial health and growth prospects.
What is Enanta Pharmaceuticals' stock symbol?
Enanta Pharmaceuticals trades on the Nasdaq stock exchange under the symbol 'ENTA'. This symbol represents the company's common stock, which provides investors the opportunity to buy shares in the firm.
What is Enanta's business model?
Enanta Pharmaceuticals operates on a business model that includes discovering and developing its proprietary drugs, while also engaging in collaborations and licensing agreements with larger pharmaceutical companies to expedite the development and commercialization of therapies in exchange for royalties and milestone payments.
What is Enanta’s pipeline of products?
Enanta has an exciting pipeline that includes product candidates in various stages of development targeting diseases such as hepatitis C, NASH, and other infections. Ongoing clinical trials aim to evaluate the safety and efficacy of these novel therapies, contributing to the company's innovation in drug discovery.
What is the significance of Enanta's drug discovery platform?
Enanta's drug discovery platform is significant because it utilizes advanced medicinal chemistry, structural biology, and biology to identify and optimize promising drug candidates. This innovative approach enables the company to effectively target complex diseases and improve patient outcomes.
What is the vision of Enanta Pharmaceuticals?
The vision of Enanta Pharmaceuticals is to develop transformative medicines for patients suffering from serious diseases, particularly viral infections. The company aims to lead in innovative therapy development by combining scientific discovery with commercial execution.
What partnerships does Enanta Pharmaceuticals have?
Enanta Pharmaceuticals has established strategic partnerships with various pharmaceutical companies, notably AbbVie, to collaborate on drug development programs which leverage each company's strengths in drug discovery and commercialization.
When was Enanta Pharmaceuticals founded?
Enanta Pharmaceuticals was founded in 1995, with the aim of addressing significant medical needs through innovative drug discovery, particularly in areas such as viral infections and rare liver diseases.
Where is Enanta Pharmaceuticals located?
Enanta Pharmaceuticals is headquartered in Watertown, Massachusetts. This location is ideal for accessing the vibrant biotech ecosystem in the Boston area, which fosters innovation and collaboration in the life sciences.
Who are the key executives at Enanta Pharmaceuticals?
The key executives at Enanta Pharmaceuticals include the CEO and co-founder, Jay Luly, and a team of experienced professionals with expertise in various fields of biotechnology, drug development, and corporate management. Their leadership drives the company's strategic direction and operational success.
What is the current price of Enanta Pharmaceuticals, Inc. - Common Stock?
The current price of Enanta Pharmaceuticals, Inc. - Common Stock is 4.600
When was Enanta Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Enanta Pharmaceuticals, Inc. - Common Stock was at 2:54 pm EDT on April 4th, 2025
What is the market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock is 96.85M
How many shares of Enanta Pharmaceuticals, Inc. - Common Stock are outstanding?
Enanta Pharmaceuticals, Inc. - Common Stock has 21.06M shares outstanding.